QuickView for RET;jsessionid=28E14966EE595DCD567764566C5CEDB0;jsessionid=90F21E5DC6AE637884667A7BEE2D8307;jsessionid=EC51C7857E9164410BC73CFEE5FA6270;jsessionid=E6BF00F35B6496993C3C0E18394EAA7A;jsessionid=3147FECF710D3FBCC6B8F8444CE87389;jsessionid=AE8E3C5C515359AD25DE3ECFC28E1DC1;jsessionid=175E186CF013A8C40CC1F07764D83792 (gene)

1. Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease an…
2. Recent developments of RET protein kinase inhibitors with diverse scaffolds as hinge binders.
3. Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both…
4. Progress and challenges in RET-targeted cancer therapy.
5. Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors.

There were no clinical trials for RET;jsessionid=28E14966EE595DCD567764566C5CEDB0;jsessionid=90F21E5DC6AE637884667A7BEE2D8307;jsessionid=EC51C7857E9164410BC73CFEE5FA6270;jsessionid=E6BF00F35B6496993C3C0E18394EAA7A;jsessionid=3147FECF710D3FBCC6B8F8444CE87389;jsessionid=AE8E3C5C515359AD25DE3ECFC28E1DC1;jsessionid=175E186CF013A8C40CC1F07764D83792